Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ines Beyer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Research|May 3, 2003
Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1Stephanie Brändlein, Ines Beyer, Matthias Eck, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumabInes Beyer, Zongyi Li, Jonas Persson, et al.
Human Antibodies|May 31, 2003
Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patientsStephanie Brändlein, Judith Lorenz, Nele Ruoff, et al.
Cancer Research|October 13, 2011
Epithelial junction opener JO-1 improves monoclonal antibody therapy of cancerInes Beyer, Ruan van Rensburg, Robert Strauss, et al.
Thrombosis Research|April 27, 2020
Rates, management and outcome of bleeding complications during edoxaban therapy in daily care - results from the DRESDEN NOAC REGISTRYJan Beyer-Westendorf, Sandra Marten, Christiane Naue, et al.
Plos One|January 26, 2011
Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticityRobert Strauss, Zong-Yi Li, Ying Liu, et al.
Stem Cells International|December 12, 2017
Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean SectionsLucas-Sebastian Spitzhorn, Md Shaifur Rahman, Laura Schwindt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2012
Coadministration of epithelial junction opener JO-1 improves the efficacy and safety of chemotherapeutic drugsInes Beyer, Hua Cao, Jonas Persson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaquesInes Beyer, Hua Cao, Jonas Persson, et al.
Journal of Virology|March 30, 2012
A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenovirusesHongjie Wang, Ines Beyer, Jonas Persson, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Research|May 3, 2003
Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1Stephanie Brändlein, Ines Beyer, Matthias Eck, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumabInes Beyer, Zongyi Li, Jonas Persson, et al.
Human Antibodies|May 31, 2003
Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patientsStephanie Brändlein, Judith Lorenz, Nele Ruoff, et al.
Cancer Research|October 13, 2011
Epithelial junction opener JO-1 improves monoclonal antibody therapy of cancerInes Beyer, Ruan van Rensburg, Robert Strauss, et al.
Thrombosis Research|April 27, 2020
Rates, management and outcome of bleeding complications during edoxaban therapy in daily care - results from the DRESDEN NOAC REGISTRYJan Beyer-Westendorf, Sandra Marten, Christiane Naue, et al.
Plos One|January 26, 2011
Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticityRobert Strauss, Zong-Yi Li, Ying Liu, et al.
Stem Cells International|December 12, 2017
Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean SectionsLucas-Sebastian Spitzhorn, Md Shaifur Rahman, Laura Schwindt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2012
Coadministration of epithelial junction opener JO-1 improves the efficacy and safety of chemotherapeutic drugsInes Beyer, Hua Cao, Jonas Persson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaquesInes Beyer, Hua Cao, Jonas Persson, et al.
Journal of Virology|March 30, 2012
A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenovirusesHongjie Wang, Ines Beyer, Jonas Persson, et al.
Pageof 3